krt14 (Novus Biologicals)
Structured Review

Krt14, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 2 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/krt14/Cytokeratin+14+Antibody+(KRT14%2F532)/pmc12837101-6-0-4
Average 93 stars, based on 2 article reviews
Images
1) Product Images from "Simultaneous generation of transplantable RGC-like and corneal progenitor cells from hiPSCs using a dual-lineage platform"
Article Title: Simultaneous generation of transplantable RGC-like and corneal progenitor cells from hiPSCs using a dual-lineage platform
Journal: Stem Cell Research & Therapy
doi: 10.1186/s13287-025-04843-z
Figure Legend Snippet: Characterization of the cultured hiPSCs derived ITGB4 + corneal cells. A Differentiation of ocular cells from hiPSCs, the representative image showed the various ocular cells, within optic vesicle and the epithelial cells area (black box). Scale bar: 200 μm. B The representative image showed the unsorted epithelial and mesenchymal cells after eliminating the neural cells. C FACS sorted ITGB4 + corneal progenitor cells from hiPSCs derived ocular cells. D Representative images of cultured ITGB4 + corneal progenitor cells. Scale bars: 50 μm. E The single cells clone forming capacity of ITGB4 + corneal progenitor cell. Scale bar: 10 μm. F Immunofluorescent staining of ITGB4 + corneal progenitor cells with ITGB4 (green), Krt14 (red), Krt12 (red), P63 (red), PAX6 (green) and Ki67(green). Scale bars: 100 μm. G The representative image of ITGB4 + corneal progenitor cell spheres. Scale bars: 200 μm. H Immunofluorescent staining of ITGB4 + corneal progenitor cell spheres with ITGB4, Krt14, Krt12 and PAX6. Scale bar: 100 μm. I , J The q-RT PCR results show the genes expression by GAPDH normalized △CT value and fold change
Techniques Used: Cell Culture, Derivative Assay, Staining, Reverse Transcription Polymerase Chain Reaction, Expressing
Figure Legend Snippet: Generation of hiPSCs derived corneal organoids. A The representative image of hiPSCs derived corneal organoids with transparent property. scale bars: 200 μm. B , C Immunofluorescent staining of corneal organoid sections with ITGB4 (green), Krt14 (red), Krt12 (red) and P63 (red). Scale bars: 100 μm and 50 μm, respectively
Techniques Used: Derivative Assay, Staining
Related Articles
In Vitro:Article Title: Framework nucleic acids as programmable carrier for transdermal drug delivery Article Snippet: .. Such sample size was chosen with referral to similar studies previously Data exclusions No data were excluded from the analyses, except for outliers as determined with Tukey's fences Replication All in vitro analyses were repeated at least three times with n>=3; all in vivo analyses were repeated at least twice Randomization Animals, ex vivo tissues were allocated randomly to different treatment groups Blinding Single blinding was performed for all animal studies, where personnel in charge of data collection and analyses is not aware of treatment conditions Reporting for specific materials, systems and methods Materials & experimental systems n/a Involved in the study Unique biological materials Antibodies Eukaryotic cell lines Palaeontology Animals and other organisms Human research participants Methods n/a Involved in the study ChIP-seq Flow cytometry MRI-based neuroimaging Unique biological materials Policy information about availability of materials Obtaining unique materials All unique materials used are available from the authors or from standard commercial sources (Sigma-Aldrich, Lonza, Gibco Thermofisher) Antibodies Antibodies used In Vivo:Article Title: Framework nucleic acids as programmable carrier for transdermal drug delivery Article Snippet: .. Such sample size was chosen with referral to similar studies previously Data exclusions No data were excluded from the analyses, except for outliers as determined with Tukey's fences Replication All in vitro analyses were repeated at least three times with n>=3; all in vivo analyses were repeated at least twice Randomization Animals, ex vivo tissues were allocated randomly to different treatment groups Blinding Single blinding was performed for all animal studies, where personnel in charge of data collection and analyses is not aware of treatment conditions Reporting for specific materials, systems and methods Materials & experimental systems n/a Involved in the study Unique biological materials Antibodies Eukaryotic cell lines Palaeontology Animals and other organisms Human research participants Methods n/a Involved in the study ChIP-seq Flow cytometry MRI-based neuroimaging Unique biological materials Policy information about availability of materials Obtaining unique materials All unique materials used are available from the authors or from standard commercial sources (Sigma-Aldrich, Lonza, Gibco Thermofisher) Antibodies Antibodies used Ex Vivo:Article Title: Framework nucleic acids as programmable carrier for transdermal drug delivery Article Snippet: .. Such sample size was chosen with referral to similar studies previously Data exclusions No data were excluded from the analyses, except for outliers as determined with Tukey's fences Replication All in vitro analyses were repeated at least three times with n>=3; all in vivo analyses were repeated at least twice Randomization Animals, ex vivo tissues were allocated randomly to different treatment groups Blinding Single blinding was performed for all animal studies, where personnel in charge of data collection and analyses is not aware of treatment conditions Reporting for specific materials, systems and methods Materials & experimental systems n/a Involved in the study Unique biological materials Antibodies Eukaryotic cell lines Palaeontology Animals and other organisms Human research participants Methods n/a Involved in the study ChIP-seq Flow cytometry MRI-based neuroimaging Unique biological materials Policy information about availability of materials Obtaining unique materials All unique materials used are available from the authors or from standard commercial sources (Sigma-Aldrich, Lonza, Gibco Thermofisher) Antibodies Antibodies used Chromatin Immunoprecipitation:Article Title: Framework nucleic acids as programmable carrier for transdermal drug delivery Article Snippet: .. Such sample size was chosen with referral to similar studies previously Data exclusions No data were excluded from the analyses, except for outliers as determined with Tukey's fences Replication All in vitro analyses were repeated at least three times with n>=3; all in vivo analyses were repeated at least twice Randomization Animals, ex vivo tissues were allocated randomly to different treatment groups Blinding Single blinding was performed for all animal studies, where personnel in charge of data collection and analyses is not aware of treatment conditions Reporting for specific materials, systems and methods Materials & experimental systems n/a Involved in the study Unique biological materials Antibodies Eukaryotic cell lines Palaeontology Animals and other organisms Human research participants Methods n/a Involved in the study ChIP-seq Flow cytometry MRI-based neuroimaging Unique biological materials Policy information about availability of materials Obtaining unique materials All unique materials used are available from the authors or from standard commercial sources (Sigma-Aldrich, Lonza, Gibco Thermofisher) Antibodies Antibodies used Flow Cytometry:Article Title: Framework nucleic acids as programmable carrier for transdermal drug delivery Article Snippet: .. Such sample size was chosen with referral to similar studies previously Data exclusions No data were excluded from the analyses, except for outliers as determined with Tukey's fences Replication All in vitro analyses were repeated at least three times with n>=3; all in vivo analyses were repeated at least twice Randomization Animals, ex vivo tissues were allocated randomly to different treatment groups Blinding Single blinding was performed for all animal studies, where personnel in charge of data collection and analyses is not aware of treatment conditions Reporting for specific materials, systems and methods Materials & experimental systems n/a Involved in the study Unique biological materials Antibodies Eukaryotic cell lines Palaeontology Animals and other organisms Human research participants Methods n/a Involved in the study ChIP-seq Flow cytometry MRI-based neuroimaging Unique biological materials Policy information about availability of materials Obtaining unique materials All unique materials used are available from the authors or from standard commercial sources (Sigma-Aldrich, Lonza, Gibco Thermofisher) Antibodies Antibodies used Magnetic Resonance Imaging:Article Title: Framework nucleic acids as programmable carrier for transdermal drug delivery Article Snippet: .. Such sample size was chosen with referral to similar studies previously Data exclusions No data were excluded from the analyses, except for outliers as determined with Tukey's fences Replication All in vitro analyses were repeated at least three times with n>=3; all in vivo analyses were repeated at least twice Randomization Animals, ex vivo tissues were allocated randomly to different treatment groups Blinding Single blinding was performed for all animal studies, where personnel in charge of data collection and analyses is not aware of treatment conditions Reporting for specific materials, systems and methods Materials & experimental systems n/a Involved in the study Unique biological materials Antibodies Eukaryotic cell lines Palaeontology Animals and other organisms Human research participants Methods n/a Involved in the study ChIP-seq Flow cytometry MRI-based neuroimaging Unique biological materials Policy information about availability of materials Obtaining unique materials All unique materials used are available from the authors or from standard commercial sources (Sigma-Aldrich, Lonza, Gibco Thermofisher) Antibodies Antibodies used Biomarker Discovery:Article Title: Framework nucleic acids as programmable carrier for transdermal drug delivery Article Snippet: .. Such sample size was chosen with referral to similar studies previously Data exclusions No data were excluded from the analyses, except for outliers as determined with Tukey's fences Replication All in vitro analyses were repeated at least three times with n>=3; all in vivo analyses were repeated at least twice Randomization Animals, ex vivo tissues were allocated randomly to different treatment groups Blinding Single blinding was performed for all animal studies, where personnel in charge of data collection and analyses is not aware of treatment conditions Reporting for specific materials, systems and methods Materials & experimental systems n/a Involved in the study Unique biological materials Antibodies Eukaryotic cell lines Palaeontology Animals and other organisms Human research participants Methods n/a Involved in the study ChIP-seq Flow cytometry MRI-based neuroimaging Unique biological materials Policy information about availability of materials Obtaining unique materials All unique materials used are available from the authors or from standard commercial sources (Sigma-Aldrich, Lonza, Gibco Thermofisher) Antibodies Antibodies used other:Article Title: Simultaneous generation of transplantable RGC-like and corneal progenitor cells from hiPSCs using a dual-lineage platform. Article Snippet: AR TIC LE IN PR ES S AR TIC LE IN PR ES S AR TIC LE IN PR ES S AR TIC LE IN PR ES S AR TIC LE IN PR ES S AR TIC LE IN PR ES S Antibodies Dilution Distributor (Cat. No) Primary antibodies: PAX6 1:100 Biolegend (901301) ITGB4 1:100 Sigma (HPA036348) TP63 1:100 Abcam (ab735) Ki67 1:100 Abcam (ab15580) KRT12 1:200 Abcam (ab185627) Article Title: Simultaneous generation of transplantable RGC-like and corneal progenitor cells from hiPSCs using a dual-lineage platform Article Snippet: |
